A. Di Savino

Publications6
h-index6
Citations146
Highly Influential Citations6
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • S. Levi
  • 166 Publications • 10,422 Citations
  • M. Brancaccio
  • 107 Publications • 2,976 Citations
  • G. Tarone
  • 245 Publications • 11,817 Citations
  • L. Silengo
  • 214 Publications • 12,165 Citations
  • Publications
  • Influence
Morgana/chp-1, a ROCK inhibitor involved in centrosome duplication and tumorigenesis.
Morgana and melusin: Two fairies chaperoning signal transduction
TLDR
Morgana and melusin are described, two phylogenetically conserved chaperones that cooperate with Hsp90 and regulate signal transduction in important physiopathological processes.
Morgana acts as a proto‐oncogene through inhibition of a ROCK–PTEN pathway
TLDR
It is demonstrated that high morgana expression in different breast cancer subtypes correlates with high tumour grade, mitosis number, and lymph node positivity and, from a mechanistic point of view, causes PTEN destabilization, by inhibiting ROCK activity, hence triggering the PI3K/AKT survival pathway.
Morgana acts as an oncosuppressor in chronic myeloid leukemia.
TLDR
It is shown that morgana (+/-) mice spontaneously develop a lethal myeloproliferative disease resembling human atypical chronic myeloid leukemia (aCML), preceded by ROCK hyperactivation, centrosome amplification, and cytogenetic abnormalities in the bone marrow.
Characterization of human mitochondrial ferritin promoter: identification of transcription factors and evidences of epigenetic control
TLDR
The expression of FTMT appears regulated by a complex mechanism involving epigenetic events and interplay between transcription factors and GATA2, FoxA1 and C/EBPβ as inhibitors of the transcriptional regulation.
Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes
TLDR
Predicting, at diagnosis, those patients with risk of treatment failure is pivotal to personalize treatments in order to improve quality of life and prolong survival and whether the expression is associated with patients’ clinical outcomes.